NCT00391495

Unknown

Inflammation in Children With Attention-Deficit/Hyperactivit...

Tel-Aviv Sourasky Medical Center Source

Compare

Other study identifiers

Sponsor study identifier

TASMC-06-NV-246-CTIL

Study Type

observational

Estimated enrollment

45

Locations

1 country

Sites

1

Timeline

Study Start

September 2007

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

December 2007

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

The aim of this study is to investigate the inflammatory response in children with this disorder.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 45 participants
Study completion date: December 2007
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
October 22, 2006
Actual (reported)
First Posted
October 24, 2006
Actual (reported)
Study Start
September 2007
Date type not reported
This date has not been verified as actual or estimated.
Study Completion
December 2007
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: June 19, 2007
Status Verified: August 2006
Last Update Submitted: June 18, 2007

Conditions

Attention-Deficit/Hyperactivity Disorder

Keywords

ADHDCytokinesCR-P

Interventions

Blood drawingProcedure

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age9 Years - 13 Years

Sexall

Healthy VolunteersYes

Age GroupsChild (0-17)

You may qualify if:

A defined condition of ADHD according to TOVA test (TOVA score \> (-1.8), Connor's questionnaire (Connor's score \> 15 points) and Achenbach's questionnaire;
A consent form signed by parents or legal guardianships;

Sponsors & Collaborators

Tel-Aviv Sourasky Medical Center
Governmentlead

Study Sites (1)

The Unit of Clinical Nutrition

Tel Aviv, Israel

Nachum Vaisman, Prof.CONTACT+972-524-266-596 vaisman@tasmc.health.gov.il

Nachum Vaisman, Prof.PRINCIPAL INVESTIGATOR

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

Nachum Vaisman, Prof. (MD)
Tel-Aviv Sourasky Medical Center
PRINCIPAL INVESTIGATOR

Central Study Contacts

Nachum Vaisman, Prof. (MD)

CONTACT

972-3-6974807 vaisman@tasmc.health.gov.il

Study Design

Study Type: observational
Observational Model: CASE CONTROL
Time Perspective: OTHER
Sponsor Type: OTHER GOV

Study Record Dates

First Submitted

October 22, 2006

First Posted

October 24, 2006

Study Start

September 2007

Date type not reported

This date has not been verified as actual or estimated.

Study Completion

December 2007

Estimated (date passed)

NCT00686933

Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase 2Completed

NCT00554385

A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Phase 2Terminated

NCT01351246

Guided Self-Help for Parents of Children With Attention-Deficit/Hyperactivity Disorder (ADHD)

Not ApplicableCompleted

NCT01104623

ADHD - Voice Analysis, Vocal Acoustic Biomarkers in Attention Deficit Hyperactivity Disorder

Unknown

NCT01081145

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Phase 3Completed

NCT01146002

Language-based Learning Skills and Attention Deficit Hyperactivity Disorder (ADHD): Impact of Treatment With Sustained-release Guanfacine

Phase 4Completed

You may not qualify if:

A history of any other neurological or major psychiatric disorder or other significant medical problems;
No current medications;

Contact the study team to confirm eligibility.

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

June 19, 2007

Record last verified: 2006-08

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00391495
Data provider: ClinicalTrials.gov
Source updated: 2007-06-19
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:34:46 UTC

Locations

IL(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Study Completion

Conditions

Keywords

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations